Vollständiger Abstract
Worum geht es in dieser Arbeit?
Abstract Thyroid Eye Disease (TED) presents various eyelid manifestations, the most common of which is eyelid retraction. Other notable manifestations include blepharoptosis, entropion, and epiblepharon (Naik MN, Walvekar P, Vasanthapuram VH, Shankar L. Ophthal Plast Reconstr Surg 39:S92-S104. https://doi.org/10.1097/IOP.0000000000002543, 2023). Eyelid surgeries are generally recommended during the inactive phase of TED, as the eyelid position can change during the active phase. These surgeries are performed for both functional and cosmetic reasons and typically represent the final step in the surgical rehabilitation process, following orbital decompression and strabismus correction (Araya J, Sabharwal S, Briceño CA. Int Ophthalmol Clin 63:91–107. https://doi.org/10.1097/IIO.0000000000000462 , 2023; Young SM, Kim YD, Lang SS, Woo KI. Ophthalmic Plast Reconstr Surg 34:587–593. https://doi.org/10.1097/IOP.0000000000001120 , 2018). However, recent research suggests that combined decompression and eyelid surgeries, particularly for eyelid retraction, can be beneficial Bernardini FP, Skippen B, Zambelli A, et al. Aesthetic Surg J 38:1052–1061. https://doi.org/10.1093/asj/sjy014 , 2018; Ben Simon GJ, Mansury AM, Schwarcz RM, et al. Ophthalmology 112:923–932. https://doi.org/10.1016/j.ophtha.2004.12.028 , 2005; Vasanthapuram VH, Naik MN. Int Ophthalmol 42:13–18. https://doi.org/10.1007/s10792-021-01992-x , 2022; Poonam NS, Agarkar S. Orbit 41:815. https://doi.org/10.1080/01676830.2022.2095649 , 2022).
Bibliografischer Nachweis
Publikationsdaten
- Autor:innen
- Shiran Madgar, Ofira Zloto
- Quelle
- Thyroid Eye Disease
- Publikation
- 2026-01-01
- Band / Ausgabe
- Nicht angegeben
- Seiten
- Nicht angegeben
- ISSN / ISBN
- Nicht angegeben
- Zitationen
- 0 laut Crossref
- Referenzen
- 0 hinterlegt
Zitieren
Zitierfähiger Nachweis
Shiran Madgar, Ofira Zloto (2026). Eyelid Surgeries for TED. Thyroid Eye Disease. https://doi.org/10.1097/01.npr.0000000000000462
Kontext
Themen, Förderung und Nutzung
Lizenzhinweise: Lizenz 1